GHSI Adds Research Leadership Ahead of the Pilot

GHSI has strengthened its research foundation, adding senior research leadership to guide how the December 2026 pilot is designed, measured, and proven.

As GHSI prepares for the pilot in Greater Accra, the project has brought on senior research leadership: a principal investigator and a co-investigator, both experienced public health researchers based in Ghana. They anchor the study design, the way outcomes are measured, and the standards that let the work hold up to scrutiny and add to the evidence base, rather than simply deliver a service and move on.

What research rigor means here

In practice, rigor means the pilot is built to measure what matters and to report its results honestly. Clear outcomes, sound tools, careful follow-up, and methods that other researchers can examine. GHSI's twelve-month closed loop, which follows each person from screening through to confirmed care, exists to produce real evidence about what works, not only a count of how many people were screened.

A curriculum still being shaped

That same standard now guides GHSI's training curriculum, which remains in development. Rather than finalize it on its own, GHSI is putting the draft through a structured review by a focus group led by the new research leadership, to test that it is evidence-grounded, clinically sound, and right for the communities it will serve. The curriculum draws on community health education methods that have published evidence behind them, and it is being adapted for Ghana's informal-sector workers, the market traders, drivers, and vendors most often missed by clinic-based care, and for teaching in local languages. The full evidence base is on our research page. It is a work in progress, and that is deliberate. Tools that will guide real screenings are worth getting right before they are used.

Why this matters

For a diaspora-led initiative, this is a choice, not an accident. The point is not to run a single event and call it impact. It is to build something durable and measurable, in partnership with the Ghanaian researchers and clinicians who will carry it long after the pilot.